Phase I/II study of NS-87 in patients with high risk acute myeloid leukemia.
Phase 1
Completed
- Conditions
- Acute myeloid leukemia
- Registration Number
- JPRN-jRCT2080224810
- Lead Sponsor
- ippon Shinyaku Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 41
Inclusion Criteria
Untreated AML patients diagnosed with therapy-related AML or AML with myelodysplasia-related changes.
Exclusion Criteria
Patients with a diagnosis of APL or favorable cytogenetics.
Patients with prior treatment intended for induction therapy of AML.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method